ABSTRACT:

HIV/AIDS is a chronic infectious disease caused by the human immunodeficiency virus, which is characterized by a spectrum starting from primary infection with or without the acute syndrome. HIV infections are a major global public health concern. In 2019, an estimated 38 million people were living with HIV infection, and 1.7 million people became newly infected. Adherence is one of the major critical things in chronic diseases like HIV/AIDS to suppress the viral replication and to decrease the impact of the disease on one’s own life through increasing quality of life and on a country by saving skilled manpower. Poor adherence is one of the major challenges in sub-Saharan African countries like Ethiopia due to factors like socio-demographic, behavioral, disease characteristics, medication-related adverse effects and health system-related factors. This study aims to know and solve the factors, increase adherence to anti-retroviral therapy and improve the quality of life for the patients. Objective: To assess the determinants of low adherence to antiretroviral therapy among patients receiving highly active antiretroviral treatment (HAART) at a selected public hospital in Addis Ababa, Ethiopia, in 2022. Methods: A cross-sectional study was conducted using convenience sampling among 220 eligible HIV-positive adult patients receiving antiretroviral therapy (ART) at Zewditu Memorial Hospital and Yekatit 12 General Hospital. Data were collected through structured questionnaire interviews and retrospective chart reviews. The data were analysed using SPSS version 25. Results were presented using frequencies, percentages, means, and standard deviations, and were displayed in tables and graphs. Result: A total of 220 study participants were included in the study, with 110 participants from Zewditu Memorial Hospital and 110 participants from Yekatit 12 General Hospital. The mean age of the participants was 41.2 years. Among the study participants, 132 (60%) were female, and 88 (40%) were male. Regarding marital status, 129 (56.4%) were unmarried. In terms of education, 91 (41.4%) had attended secondary school, while 131 (59.5%) had completed their secondary education. Conclusion: In our study, the majority of participants demonstrated good adherence to treatment. However, the proportion of individuals with poor adherence was still considerable. Additionally, none of the assessed factors showed a significant association with poor adherence.

KEYWORDS :

Adherence, Antiretroviral Therapy (ART), Determinants, HIV/AIDS

REFERENCES :

1) Ethiopia Public Health Training Initiative, The Carter Center, Ministry of Health, & Ministry of Education. (2006 E.C.). Ethiopian Internal Medicine Lecture Notes for Health Officer (2nd ed.). Available at: https://www.cartercenter.org. Accessed on April 23, 2022. 2) Food, Medicine and Health Care Administration and Control Authority (FMHACA). (2014 E.C.). Ethiopian Standard Treatment Guideline for General Hospitals (3rd ed.). Available at: https://www.fmhaca.gov.et. Accessed on May 2, 2022. 3) Lailulo, Y., Kitonye, M., et al. (2020). Factors associated with anti-retroviral therapy treatment failure among people living with HIV in resource-poor settings: A systematic review and meta-analysis. Systematic Reviews, 9, 292. https://doi.org/10.1186/s13643-020-01524-1 4) UNAIDS. (2021). UNAIDS report on the global AIDS epidemic. Available at: https://www.unaids.org/sites/default/files/media_asset/UNAIDS-fact-sheet.pdf. Accessed in 2022. 5) Aschilum, S.B., Tadesse, A.W., Urmale, M.K., et al. (2021). Level of nonadherence and its associated factors among adults on first-line ART. PLoS ONE, 16(8): e0255912. https://doi.org/10.1371/journal.pone.0255912 6) World Health Organization (WHO). (2007, December). ART failure and strategies for switching ART regimens in the WHO European Region. Accessed on April 25, 2022. 7) Centers for Disease Control and Prevention (CDC). (2011, August). HIV/AIDS Prevention Division. Available at: https://www.cdc.gov/hiv. Accessed on April 25, 2022. 8) Adal, M. (2019). Systematic review on HIV situation in Addis Ababa, Ethiopia. BMC Public Health, 19, 1544. https://doi.org/10.1186/s12889-019-7885-8 9) Ago, K.A., Oqua, D., Omonaiga, O., et al. (2011). Medication adherence and risk factors for non-adherence among patients on HAART. Journal of West African Pharmacy, 22(1), 19–26. 10) Homschuh, S., Dietrich, J.J., Tshabalala, C., Lager, F. (2017). ART adherence knowledge and experience among adolescents and young adults. Journal of South Africa Research on AIDS Treatment, 2017: 1–8. https://doi.org/10.1155/2017/9259256 11) Mai, H.T., Le, M.G., Tram, B.X., et al. (2018). ART adherence in the context of early treatment in Vietnam. Patient Preference and Adherence, 12, 2131–2137. https://doi.org/10.2147/PPA.S175474 12) Calvetti, P.U., Giovelli, G.R.M., Gayer, G.J.C., Morales, J.F.D. (2014). Psychosocial factors and quality of life in ART adherence. Journal of Brazil, 63(1), 8–15. 13) Miyada, S., Harbin, A.J.I., Gatto, R.C.J., Garbin, C.A.S. (2017). Treatment adherence in HIV patients. Journal of the Brazilian Society of Tropical Medicine, 50(5), 607–612. 14) Suryana, K., Suharsono, H., et al. (2019). Factors associated with ART adherence in Indonesia. Journal of Indonesia, 11, 307–312. https://doi.org/10.2147/HIV.S219695 15) Andini, S., Waluyo, A., et al. (2019). Self-efficacy, depression, and ART adherence among women with HIV. Journal of Indonesia, 29(Suppl. 2), 687–690. https://doi.org/10.1016/j.enfcli.2019.04.105 16) Oliveira, L.S., Caixeta, L.M., Martins, J.L.R., et al. (2018). ART adherence, adverse effects, and co-infection. Journal of the Brazilian Society of Tropical Medicine, 51(4), 436–444. https://doi.org/10.1590/0037-8682-0467-2017 17) Dorcelus, L., Bernard, J., et al. (2021). Factors affecting ART adherence in Haiti. Journal of Haiti Research on AIDS, 18, 81. https://doi.org/10.1186/s12981-021-00405-4 18) Semvua, S.K., Orrell, C., Mmbaya, B.T., et al. (2017). Predictors of ART non-adherence in Tanzania. PLoS ONE, 12(12), e0189460. https://doi.org/10.1371/journal.pone.0189460 19) Byabene, A.K., Deguenonvo, L.F., Niang, K., et al. (2017). CASE index score and virological suppression. Tropical Medicine & International Health, 22(6), 776–782. https://doi.org/10.1111/tmi.12882 20) Legesse, T.A., Reta, M.B. (2019). ART adherence in Hara town, Ethiopia. Ethiopian Journal of Health Sciences, 29(2), 299. https://doi.org/10.4314/ejhs.v29i2.2 21) Azial, N., Mukumbany, F.C., Vanwyk, B. (2016). Barriers to ART adherence. South African Journal of HIV Medicine, 17(1), a476. https://doi.org/10.4102/sajhivmed.v17i1.476 22) Letta, S., Demissie, A., et al. (2015). Factors associated with ART adherence in Ethiopia. BMC International Health and Human Rights, 15, 33. https://doi.org/10.1186/s12914-015-0070-x 23) Abadiga, M., Hansen, T., et al. (2019). ART adherence and associated factors. PLoS ONE, 15(5), e0232703. https://doi.org/10.1371/journal.pone.0232703 24) Nigussu, F.T., Mudzusi, A.H.M. (2020). Non-adherence magnitude in Benishangul Gumuz. PeerJ, 8, e8558. https://doi.org/10.7717/peerj.8558 25) Tessema, G.A., Kassa, H. (2014). ART adherence in children. BMC Public Health, 14, 365. 26) Anuradha, S., Joshi, A., et al. (2011). ART adherence under India’s national program. Indian Journal of Community Medicine, 12(3), 195–201. https://doi.org/10.1177/1454109711431344